Artículos de revistas sobre el tema "SCD89"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "SCD89".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Berthelot, Laureline, Christina Papista, Thiago T. Maciel, Martine Biarnes-Pelicot, Emilie Tissandie, Pamela H. M. Wang, Houda Tamouza et al. "Transglutaminase is essential for IgA nephropathy development acting through IgA receptors". Journal of Experimental Medicine 209, n.º 4 (26 de marzo de 2012): 793–806. http://dx.doi.org/10.1084/jem.20112005.
Texto completoWu, Haiting, Xiaoyan Wang, Zhe Yang, Qing Zhao, Yubing Wen, Xuemei Li, Wei Zhang y Ruitong Gao. "Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History". Disease Markers 2020 (16 de enero de 2020): 1–6. http://dx.doi.org/10.1155/2020/8393075.
Texto completovan Zandbergen, Ger, Ralf Westerhuis, Ngaisah Klar Mohamad, Jan G. J. van de Winkel, Mohamed R. Daha y Cees van Kooten. "Crosslinking of the Human Fc Receptor for IgA (FcαRI/CD89) Triggers FcR γ-Chain-Dependent Shedding of Soluble CD89". Journal of Immunology 163, n.º 11 (1 de diciembre de 1999): 5806–12. http://dx.doi.org/10.4049/jimmunol.163.11.5806.
Texto completoDi Leo, Vincenzo, Patrick J. Gleeson, Fabio Sallustio, Carine Bounaix, Jennifer Da Silva, Gesualdo Loreto, Sanae Ben Mkaddem y Renato C. Monteiro. "Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model". Journal of Personalized Medicine 11, n.º 4 (16 de abril de 2021): 309. http://dx.doi.org/10.3390/jpm11040309.
Texto completoEsteve Cols, Clara, Freddzia-Amanda Graterol Torres, Bibiana Quirant Sánchez, Helena Marco Rusiñol, Maruja Isabel Navarro Díaz, Jordi Ara del Rey y Eva Mª Martínez Cáceres. "Immunological Pattern in IgA Nephropathy". International Journal of Molecular Sciences 21, n.º 4 (18 de febrero de 2020): 1389. http://dx.doi.org/10.3390/ijms21041389.
Texto completoZych, Michał, Aleksander Roszczyk, Filip Dąbrowski, Monika Kniotek y Radosław Zagożdżon. "Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss—A Preliminary Study". International Journal of Molecular Sciences 25, n.º 1 (29 de diciembre de 2023): 499. http://dx.doi.org/10.3390/ijms25010499.
Texto completoLiu, Chao, Xiaohui Li, Aijie Li, Wenxue Zou, Rui Huang, Xiaoyu Hu, Jinming Yu, Xiaoling Zhang y Jinbo Yue. "Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer". Journal of Immunology Research 2022 (4 de abril de 2022): 1–8. http://dx.doi.org/10.1155/2022/9621466.
Texto completoOdagiri, Naoshi, Hoang Hai, Le Thi Thanh Thuy, Minh Phuong Dong, Maito Suoh, Kohei Kotani, Atsushi Hagihara et al. "Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization". Cancers 12, n.º 8 (24 de julio de 2020): 2045. http://dx.doi.org/10.3390/cancers12082045.
Texto completoKAKOULIDOU, M., X. WANG, X. ZHAO, R. PIRSKANEN y A. LEFVERT. "Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis". Journal of Neuroimmunology 185, n.º 1-2 (abril de 2007): 150–61. http://dx.doi.org/10.1016/j.jneuroim.2007.01.007.
Texto completoLin, Wei. "sCD83 alleviates experimental autoimmune uveitis through disrupting the regulation of Rab1a/LRRK2 on F-actin rearrangements". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 116.2. http://dx.doi.org/10.4049/jimmunol.202.supp.116.2.
Texto completoZelek, Wioleta M., Lewis M. Watkins, Owain W. Howell, Rhian Evans, Sam Loveless, Neil P. Robertson, Marijke Beenes, Loek Willems, Ricardo Brandwijk y B. Paul Morgan. "Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59". Multiple Sclerosis Journal 25, n.º 4 (9 de febrero de 2018): 523–31. http://dx.doi.org/10.1177/1352458518758927.
Texto completoKang, Seon Mee, Jun Choul Lee y Bon Jeong Ku. "Changes in Soluble Serum CD81 Concentration during an Oral Glucose Tolerance Test in Patients with Diabetes Mellitus and Individuals with Normal Glucose Tolerance". Diagnostics 13, n.º 23 (21 de noviembre de 2023): 3500. http://dx.doi.org/10.3390/diagnostics13233500.
Texto completoLiu, Shen, Chaoqun Huang, Dawei Li, Weihua Ren, Haoxing Zhang, Meiyan Qi, Xin Li y Long Yu. "Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase/reductase 9." Acta Biochimica Polonica 54, n.º 1 (20 de febrero de 2007): 213–18. http://dx.doi.org/10.18388/abp.2007_3289.
Texto completoEinenkel, Rebekka, Katrin Regina Helene Packhäuser, Jens Ehrhardt, Anne Tüngler, Marek Zygmunt y Damián Oscar Muzzio. "CD83 is locally regulated and differentially expressed in disturbed murine pregnancy". Reproduction 158, n.º 4 (octubre de 2019): 323–33. http://dx.doi.org/10.1530/rep-19-0171.
Texto completoLinker-Israeli, M., S. Hyun, T. Ozeri-Chen, D. J. Wallace, K. Banks y J. R. Klinenberg. "Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus." Journal of Immunology 152, n.º 6 (15 de marzo de 1994): 3158–67. http://dx.doi.org/10.4049/jimmunol.152.6.3158.
Texto completoGong, Xingyu, Tianyi Ma, Qiaoya Zhang, Yanhong Wang, Chengchuang Song, Min Lai, Chunlei Zhang, Xingtang Fang y Xi Chen. "Porcine Reproductive and Respiratory Syndrome Virus Modulates the Switch of Macrophage Polarization from M1 to M2 by Upregulating MoDC-Released sCD83". Viruses 15, n.º 3 (17 de marzo de 2023): 773. http://dx.doi.org/10.3390/v15030773.
Texto completoIshibashi, Mariko, Ryosuke Kinoshita, Koiti Inokuchi, Hiroshi Handa, Makoto Sasaki, Norio Komatsu, Yoichi Imai et al. "Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression". Blood 134, Supplement_1 (13 de noviembre de 2019): 4361. http://dx.doi.org/10.1182/blood-2019-124635.
Texto completoMuñiz, Carmen, Lourdes Martín-Martín, Antonio López, Blanca Sánchez-González, Antonio Salar, Julia Almeida, Juan-Manuel Sancho et al. "Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome". Blood 123, n.º 12 (20 de marzo de 2014): 1864–69. http://dx.doi.org/10.1182/blood-2013-11-537993.
Texto completoHo, AD, M. Grossman, L. Trumper, A. Pezzutto, H. Pralle, S. Boedewadt-Radzun, U. Papendick, B. God, T. Zwingers y W. Hunstein. "Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia". Blood 75, n.º 5 (1 de marzo de 1990): 1119–24. http://dx.doi.org/10.1182/blood.v75.5.1119.bloodjournal7551119.
Texto completoHo, AD, M. Grossman, L. Trumper, A. Pezzutto, H. Pralle, S. Boedewadt-Radzun, U. Papendick, B. God, T. Zwingers y W. Hunstein. "Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia". Blood 75, n.º 5 (1 de marzo de 1990): 1119–24. http://dx.doi.org/10.1182/blood.v75.5.1119.1119.
Texto completoLundell, Anna-Carin, Kerstin Andersson, Elisabet Josefsson, Alexander Steinkasserer y Anna Rudin. "Soluble CD14 and CD83 from Human Neonatal Antigen-Presenting Cells Are Inducible by Commensal Bacteria and Suppress Allergen-Induced Human Neonatal Th2 Differentiation". Infection and Immunity 75, n.º 8 (25 de mayo de 2007): 4097–104. http://dx.doi.org/10.1128/iai.01744-06.
Texto completoKogure, T., T. Itoh, Y. Shimada, T. Shintani, H. Ochiai y K. Terasawa. "Detection of serum soluble markers of immune activation in rheumatoid arthritis". Mediators of Inflammation 5, n.º 4 (1996): 262–65. http://dx.doi.org/10.1155/s0962935196000373.
Texto completoOlszewski, Jurek, Wiesław Chudzik, Kazimierz Wiśniewski, Jarosław Miłonski y Robert Matyja. "An Assessment of Concentrations of Soluble CD4 and CD8 Receptors in Serum before and after Surgical Treatment in Patients with Chronic Maxillary Sinusitis". American Journal of Rhinology 17, n.º 3 (mayo de 2003): 123–26. http://dx.doi.org/10.1177/194589240301700301.
Texto completoPeckert-Maier, Katrin, Dmytro Royzman, Pia Langguth, Anita Marosan, Astrid Strack, Atefeh Sadeghi Shermeh, Alexander Steinkasserer, Elisabeth Zinser y Andreas B. Wild. "Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation". International Journal of Molecular Sciences 23, n.º 2 (10 de enero de 2022): 732. http://dx.doi.org/10.3390/ijms23020732.
Texto completoKubysheva, Nailya, Larisa Postnikova, Svetlana Soodaeva, Viкtor Novikov, Tatyana Eliseeva, Ildar Batyrshin, Timur Li, Igor Klimanov y Alexander Chuchalin. "Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients". Disease Markers 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/8216723.
Texto completoYin, Xin-Ke, Chao Wang, Li-Li Feng, Shao-Mei Bai, Wei-Xing Feng, Neng-Tai Ouyang, Zhong-Hua Chu, Xin-Juan Fan y Qi-Yuan Qin. "Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy". Cancers 14, n.º 22 (14 de noviembre de 2022): 5573. http://dx.doi.org/10.3390/cancers14225573.
Texto completoMoretti, Edgardo, Beatriz Basso, Liliana Cervetta, Ana Brigada y Gustavo Barbieri. "Patterns of Cytokines and Soluble Cellular Receptors in the Sera of Children with Acute Chagas' Disease". Clinical and Vaccine Immunology 9, n.º 6 (noviembre de 2002): 1324–27. http://dx.doi.org/10.1128/cdli.9.6.1324-1327.2002.
Texto completoJiang, Chun-Xuan. "THE PRIME PRINCIPLE IN CLUSTERS AND NANOSTRUCTURES". Algebras Groups and Geometries 39, n.º 2 (1 de diciembre de 2023): 189–95. http://dx.doi.org/10.29083/agg.39.02.2023/sc189.
Texto completoHo, AD, M. Maruyama, A. Maghazachi, JR Mason, S. Gluck y RE Corringham. "Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation". Blood 84, n.º 10 (15 de noviembre de 1994): 3550–57. http://dx.doi.org/10.1182/blood.v84.10.3550.3550.
Texto completoHo, AD, M. Maruyama, A. Maghazachi, JR Mason, S. Gluck y RE Corringham. "Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation". Blood 84, n.º 10 (15 de noviembre de 1994): 3550–57. http://dx.doi.org/10.1182/blood.v84.10.3550.bloodjournal84103550.
Texto completoHo, AD, R. Haas, G. Wulf, W. Knauf, R. Ehrhardt, B. Heilig, M. Korbling, G. Schulz y W. Hunstein. "Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma". Blood 75, n.º 1 (1 de enero de 1990): 203–12. http://dx.doi.org/10.1182/blood.v75.1.203.203.
Texto completoHo, AD, R. Haas, G. Wulf, W. Knauf, R. Ehrhardt, B. Heilig, M. Korbling, G. Schulz y W. Hunstein. "Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma". Blood 75, n.º 1 (1 de enero de 1990): 203–12. http://dx.doi.org/10.1182/blood.v75.1.203.bloodjournal751203.
Texto completoPutz, D., U. Barnas, A. Luger, G. Mayer, W. Woloszczuk y H. Graf. "Biocompatibility of High-Flux Membranes". International Journal of Artificial Organs 15, n.º 8 (agosto de 1992): 456–60. http://dx.doi.org/10.1177/039139889201500802.
Texto completoHamed, Nahla, Nahla Farahat, Manal El Sorady, Dalia Nafee y Sherine Barakat. "Clinical significance of sCD86 levels in patients with acute myelogenous leukemia". Alexandria Journal of Medicine 47, n.º 1 (1 de marzo de 2011): 25–30. http://dx.doi.org/10.1016/j.ajme.2011.04.002.
Texto completoNascimento, Catarina, Andreia Gameiro, Jorge Correia, João Ferreira y Fernando Ferreira. "The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications". Cells 11, n.º 16 (18 de agosto de 2022): 2578. http://dx.doi.org/10.3390/cells11162578.
Texto completoKashchenko, Mikhail. "INTERPRETATION OF THE MECHANISM OF THE INFLUENCE OF π0- MESONS ON THE PROCESS OF ATTRACTION OF NUCLEI". Hadronic Journal 47, n.º 1 (1 de marzo de 2024): 89–94. http://dx.doi.org/10.29083/hj.47.01.2024/sc89.
Texto completoDíaz García, Elena, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, José Juan Ruíz Hernández et al. "Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation". IBJ Plus 1, s5 (3 de junio de 2022): 1. http://dx.doi.org/10.24217/2531-0151.22v1s5.00001.
Texto completoBarlan, Işil B., M. M. Başaran, M. Bakir, F. Tükenmez y Nural Bekiroğlu. "Serum TNF-α, sCD8 and sIL-2R levels in childhood tuberculosis". Infection 23, n.º 4 (julio de 1995): 237–39. http://dx.doi.org/10.1007/bf01781205.
Texto completoPujalte, J. M. "Présence pulmonaire de sCD87 au cours du syndrome de détresse respiratoire aiguë (SDRA)". Revue des Maladies Respiratoires 21, n.º 6 (diciembre de 2004): 1212. http://dx.doi.org/10.1016/s0761-8425(04)71619-8.
Texto completoSpathas, Nikolaos, Anna C. Goussia, Georgia-Angeliki Koliou, Helen Gogas, Flora Zagouri, Anna Batistatou, Antonia V. Charchanti et al. "Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study". Cancers 14, n.º 22 (16 de noviembre de 2022): 5635. http://dx.doi.org/10.3390/cancers14225635.
Texto completoOzkorucu, Duygu, Nuran Cetin, Nadide Melike Sav y Bilal Yildiz. "Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome". International Urology and Nephrology 48, n.º 7 (27 de febrero de 2016): 1187–96. http://dx.doi.org/10.1007/s11255-016-1249-4.
Texto completoSanders, David E., Mark S. Stave, Leslie S. Perkins y Andrew E. DePristo. "SCT89: a computer code for atomic and molecular scattering from clean and adsorbate covered surfaces". Computer Physics Communications 70, n.º 3 (julio de 1992): 579–608. http://dx.doi.org/10.1016/0010-4655(92)90118-i.
Texto completoDe Rie, MA, IM Zonneveld, L. Witkamp, RA Van Lier, TA Out y JD Bos. "Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1." Acta Dermato-Venereologica 76, n.º 5 (1 de septiembre de 1996): 357–60. http://dx.doi.org/10.2340/0001555576357360.
Texto completoKuryliszyn-Moskal, A., K. Bemacka y O. Bielecka. "Soluble CD4 (sCD4), CD8 (sCD8) and cytokine levels in rheumatoid arthritis complicated by vasculitis". Immunology Letters 56 (mayo de 1997): 321. http://dx.doi.org/10.1016/s0165-2478(97)86296-7.
Texto completoKuryliszyn-Moskal, A. "Soluble CD4 (sCD4), CD8 (sCD8) and cytokine levels in rheumatoid arthritis complicated by vasculitis". Immunology Letters 56, n.º 1-3 (mayo de 1997): 321. http://dx.doi.org/10.1016/s0165-2478(97)88134-5.
Texto completoBrasoveanu, L. I., E. Fonsatti, A. Visintin, M. Pavlovic, I. Cattarossi, F. Colizzi, A. Gasparollo et al. "Melanoma cells constitutively release an anchor-positive soluble protectin (sCD59) that retains functional activities in complement-mediated cytotoxicity". Melanoma Research 7, Supplement 1 (junio de 1997): S10. http://dx.doi.org/10.1097/00008390-199706001-00034.
Texto completoKim, Han-Soo, Dimitrios Degiannis, Jana Raskova y Karel Raska. "Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: Correlation with proliferative responses". Clinical Immunology and Immunopathology 60, n.º 1 (julio de 1991): 27–39. http://dx.doi.org/10.1016/0090-1229(91)90109-n.
Texto completovan der Merwe, P. Anton, Dale L. Bodian, Susan Daenke, Peter Linsley y Simon J. Davis. "CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics". Journal of Experimental Medicine 185, n.º 3 (3 de febrero de 1997): 393–404. http://dx.doi.org/10.1084/jem.185.3.393.
Texto completoCaruso, C., G. Candore, D. Cigna, S. Tripi, G. Di Gaetano, G. Migneco, G. Montalto, I. Ruggieri y A. Notarbartolo. "Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis". Mediators of Inflammation 3, n.º 3 (1994): 185–87. http://dx.doi.org/10.1155/s0962935194000256.
Texto completoMartens, A., RAJ Janssen, DTh Sleijfer, AA Heijn, NH Mulder, TH The y L. de Leij. "Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response". British Journal of Cancer 67, n.º 5 (mayo de 1993): 1118–21. http://dx.doi.org/10.1038/bjc.1993.205.
Texto completo